The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Lymphocyte responses and cytokines
Paul, W. E., & Seder, R. A. (1994) · Cell · doi:10.1016/0092-8674(94)90332-8 · Cited by 1,828
The IL-4 receptor: signaling mechanisms and biologic functions
Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., & Paul, W. E. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.701 · Cited by 1,545
Lymphokine Production by Human T Cells in Disease States
Romagnani, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.227 · Cited by 1,343
Dermatology in General Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_2 · Cited by 1,237
Krueger, G. G., Koo, J. Y. M., Lebwohl, M., Menter, A., Stern, R. S., & Rolstad, T. (2001) · PubMed · Cited by 969
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Chaudhari, U., Romano, P., Mulcahy, L., Dooley, L., Baker, D., & Gottlieb, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04954-0 · Cited by 890
CCR5 is characteristic of Th1 lymphocytes
Loetscher, P., Uguccioni, M., Bordoli, L., Baggiolini, M., Moser, B., Chizzolini, C., & Dayer, J.-M. (1998) · Nature · doi:10.1038/34814 · Cited by 866
Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J. A., et al. (2000) · Nature Medicine · doi:10.1038/80516 · Cited by 823
Gottlieb, S. L., Gilleaudeau, P., Johnson, R., Estes, L., Woodworth, T. G., Gottlieb, A. B., & Krueger, J. G. (1995) · Nature Medicine · doi:10.1038/nm0595-442 · Cited by 606
Mack, M., Kleinschmidt, A., Brühl, H., Klier, C., Nelson, P. J., Cihak, J., Plachý, J., Stangassinger, M., Erfle, V., & Schlöndorff, D. (2000) · Nature Medicine · doi:10.1038/77498 · Cited by 605
Self-citationCytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.
Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M., & Röcken, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1961 · Cited by 594
Self-citationTreatment of Chronic Plaque Psoriasis by Selective Targeting of Memory Effector T Lymphocytes
Ellis, C. N., & Krueger, G. G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450403 · Cited by 582
Blumberg, H., Conklin, D., Xu, W., Grossmann, A., Brender, T., Carollo, S., Eagan, M., Foster, D., Haldeman, B. A., Hammond, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00187-8 · Cited by 547
Kappos, L., Comi, G., Panitch, H., Oger, J., Antel, J., Conlon, P., Steinman, L., Comi, G., Kappos, L., Oger, J., et al. (2000) · Nature Medicine · doi:10.1038/80525 · Cited by 512
Austin, L. M., Ozawa, M., Kikuchi, T., Walters, I. B., & Krueger, J. G. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00749.x · Cited by 485
Inflammatory Skin Diseases, T Cells, and Immune Surveillance
Robert, C., & Kupper, T. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412407 · Cited by 475
Kamradt, T., & Mitchison, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440907 · Cited by 457
Biedermann, T., Kneilling, M., Mailhammer, R., Maier, K., Sander, C. A., Kollias, G., Kunkel, S. L., Hültner, L., & Röcken, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1441 · Cited by 395
Self-citationThe interleukin-10 family of cytokines
Fickenscher, H., Hör, S., Küpers, H., Knappe, A., Wittmann, S., & Sticht, H. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02149-4 · Cited by 331
Abrams, J. R., Kelley, S. L., Hayes, E., Kikuchi, T., Brown, M. J., Kang, S., Lebwohl, M. G., Guzzo, C. A., Jegasothy, B. V., Linsley, P. S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.681 · Cited by 318
Nestle, F. O., Turka, L. A., & Nickoloff, B. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117308 · Cited by 306
IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice
Biedermann, T., Zimmermann, S., Himmelrich, H., Gumy, A., Egeter, O., Sakrauski, A. K., Seegmüller, I., Voigt, H., Launois, P., Levine, A. D., et al. (2001) · Nature Immunology · doi:10.1038/ni725 · Cited by 294
Self-citationMazzucchelli, L., Hauser, C. J., Z’graggen, K., Wagner, H., Hess, M. W., Laissue, J. A., & Mueller, C. (1994) · PubMed Central · Cited by 286
Sornasse, T., Larenas, P. V., Davis, K. A., de Vries, J. E., & Yssel, H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.473 · Cited by 269
IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease
Röcken, M., Racke, M., & Shevach, E. M. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80556-1 · Cited by 264
Self-citationInjection of Pre-Psoriatic Skin with CD4+ T Cells Induces Psoriasis
Nickoloff, B. J., & Wrone-Smith, T. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65109-7 · Cited by 260
Trepicchio, W. L., Ozawa, M., Walters, I. B., Kikuchi, T., Gilleaudeau, P., Bliss, J. L., Schwertschlag, U., Dorner, A. J., & Krueger, J. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6910 · Cited by 217
Cyclosporine consensus conference: With emphasis on the treatment of psoriasis
Lebwohl, M., Ellis, C., Gottlieb, A., Koo, J., Krueger, G., Linden, K., Shupack, J., & Weinstein, G. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70325-1 · Cited by 187
Kaliński, P., Smits, H. H., Schuitemaker, J. H. N., Vieira, P. L., van Eijk, M., de Jong, E. C., Wierenga, E. A., & Kapsenberg, M. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1877 · Cited by 177
Reich, K., Blaschke, V., Maurer, C., Lippert, U., Neumann, C. R., Garbe, C., Middel, P., & Westphal, G. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01248.x · Cited by 124
Wong, H. L., Costa, G. L., Lotze, M. T., & Wahl, S. M. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.3.775 · Cited by 90
Biedermann, T., Mailhammer, R., Mai, A., Sander, C., Ogilvie, A. L. J., Brombacher, F., Maier, K., Levine, A. D., & Röcken, M. (2001) · European Journal of Immunology · Cited by 89
Self-citationPsoralen Bath Plus UV-A Therapy
Lüftl, M. (1997) · Archives of Dermatology · doi:10.1001/archderm.1997.03890480123023 · Cited by 83
Asadullah, K., Friedrich, M., Hanneken, S., Rohrbach, C., Audring, H., Ebeling, M., Sterry, W., Vergopoulos, A., Döcke, W., & Volk, H. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01317.x · Cited by 76
Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo.
Röcken, M., Urban, J. F., & Shevach, E. M. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.6.1885 · Cited by 71
Self-citationGranstein, R. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450410 · Cited by 37
Safety Evaluation of Recombinant Human Interleukin-4
Leach, M. W., Snyder, E. A., Sinha, D. P., & Rosenblum, I. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4303 · Cited by 30
Breit, S., Steinhoff, M., Blaser, K., Heusser, C., Sebald, W., Levine, A. D., & Röcken, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260829 · Cited by 29
Self-citationEe, V., Figlin, R. A., Höchster, H. S., Lotze, M. T., & Rybak, M. E. (1998) · PubMed · Cited by 23
Safety Evaluation of Recombinant Human Interleukin-4
Leach, M. W., Rybak, M. E., & Rosenblum, I. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4304 · Cited by 18
Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Rodriguez-Palmero, M. (1999) · doi:10.1002/(sici)1521-4141(199912)29:12<3914::aid-immu3914>3.0.co;2-#
Cited by
Schön, M. P., & Boehncke, W.-H. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041320 · Cited by 955
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
Ghoreschi, K., Balato, A., Enerbäck, C., & Sabat, R. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00184-7 · Cited by 668
Self-citationRecent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
Nickoloff, B. J., & Nestle, F. O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422147 · Cited by 544
CD4 + T-cell subsets in inflammatory diseases: beyond the T h 1/T h 2 paradigm
Hirahara, K., & Nakayama, T. (2016) · International Immunology · doi:10.1093/intimm/dxw006 · Cited by 417
Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics
Ding, D., & Zhu, Q. (2018) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.12.036 · Cited by 386
Metadata
- Authors
- Ghoreschi, K., Thomas, P., Breit, S., Dugas, M., Mailhammer, R., van Eden, W., van der Zee, R., Biedermann, T., Prinz, J., Mack, M., Mrowietz, U., Christophers, E., Schlöndorff, D., Plewig, G., Sander, C. A., & Röcken, M.
- Venue
- Nature Medicine
- Published
- 2002-12-02
- Volume
- 9
- Issue
- 1
- Pages
- 40-46
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2008419958
- Cited by
- 453
- References
- 44
- FWCI
- 10.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.